Cogent Biosciences, Inc.
COGT
Jodie situation report
Cogent Biosciences, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 37 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 2 directly disclosed connections are confirming.
- COGT's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if COGT's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind COGT
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
TISIFiling-linked namepartnerMay 5, 2026 ▾
“This is due to the numerous risks and uncertainties associated with product development and commercialization, including the following: • the timing and progress of our preclinical and clinical development activities; • the number and scope of preclinical and…”
SLRCSLR Investment Corp.lenderMay 5, 2026 ▾
“75 On June 11, 2025, we entered into a loan and security agreement (the “Loan and Security Agreement”) with SLR Investment Corp.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
COGT is currently a Early Follower in the organic co-movement group Biotechnology. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.